Cargando…
Comparison of Glibenclamide and Insulin on Neonatal Outcomes in Pregnant Women with Gestational Diabetes
BACKGROUND: Untreated or poorly controlled gestational diabetes can cause serious complications for mother and newborn. Glibenclamide is rarely used in treating mothers with this disease. This study aimed at comparing the effect of glibenclamide and insulin on neonatal outcomes in women with gestati...
Autores principales: | Behrashi, Mitra, Samimi, Mansooreh, Ghasemi, Tayyebeh, Saberi, Farzaneh, Atoof, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926540/ https://www.ncbi.nlm.nih.gov/pubmed/27413519 http://dx.doi.org/10.4103/2008-7802.184502 |
Ejemplares similares
-
Comparison of Newborn Outcomes in Women with Gestational Diabetes Mellitus Treated with Metformin or Insulin: A Randomised Blinded Trial
por: Mesdaghinia, Elahe, et al.
Publicado: (2013) -
Vaginal Candidiasis Complications on Pregnant Women
por: Rasti, Sima, et al.
Publicado: (2014) -
Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis
por: Balsells, Montserrat, et al.
Publicado: (2015) -
Maternal and Neonatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus Treated with Diet, Metformin or Insulin
por: Simeonova-Krstevska, Slagjana, et al.
Publicado: (2018) -
Association between markers of systemic inflammation, oxidative stress, lipid profiles, and insulin resistance in pregnant women
por: Asemi, Zatollah, et al.
Publicado: (2013)